Real-World Comparative Effectiveness of Donanemab Plus Usual Care Versus Usual Care Alone in US Patients with Early Symptomatic Alzheimer’s Disease
Clinical Trial Information
Trial Contact: Carlo, Charlene S, Colon Morales, Veronica J, Mondragon, Diana
Trial Phone: 321.841.1324, 407-687-3769, 3218414717
IRB No: RNE
Principal Investigator: Mohiuddin, Yasmin
Phase: N/A
Age Group: Adult
ClinicalTrials.gov ID: NCT 06566170
Objective
To compare the effect of donanemab and Usual Care versus Usual Care alone on dependence level in participants with early symptomatic AD